Your account is not claimed yet. You can sign up with ORCID to claim your account.

Win Topatana

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Immunotherapy

Journal of gastroenterology and hepatology

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

NPJ precision oncology

Zhejiang University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Zhejiang University

China

MSC :: School of Medicine

Publications

Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)
Sarun Juengpanich, Shijie Li, Taorui Yang, Tianao Xie, Jiadong Chen, Yukai Shan, Jiyoung Lee, Ziyi Lu, Tianen Chen, Bin Zhang, Jiasheng Cao, Jiahao Hu, Jicheng Yu, Yanfang Wang, Win Topatana, Zhen Gu, Xiujun Cai, Ming-Yu Chen
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer. Nature communications 14 (1) (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)
Jiasheng Cao, Jiafei Yan, Jiahao Hu, Bin Zhang, Win Topatana, Shijie Li, Tianen Chen, Sarun Jeungpanich, Ziyi Lu, Shuyou Peng, Xiujun Cai, Ming-Yu Chen
Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection. Cancer medicine (2023)
Ming-Yu Chen, Sarun Juengpanic, Shijie Li, Win Topatana, Ziyi Lu, Qiang Zheng, Jiasheng Cao, Jiahao Hu, Esther Chan, Lidan Hou, Jiang Chen, Fang Chen, Yu Liu, Sukanda Jiansirisomboon, Zhen Gu, Suparat Tongpeng, Xiujun Cai
Bortezomib-Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (7) (2022)
Ming-Yu Chen, Bin Zhang, Win Topatana, Jiasheng Cao, Hepan Zhu, Sarun Juengpanich, Qijiang Mao, Hong Yu, Xiujun Cai
Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning. NPJ precision oncology 4 (2020)
Shijie Li, Win Topatana, Sarun Juengpanich, Jiasheng Cao, Jiahao Hu, Bin Zhang, Diana Ma, Xiujun Cai, Ming-Yu Chen
Development of synthetic lethality in cancer: molecular and cellular classification. Signal transduction and targeted therapy 5 (1) (2020)
Anxin Chen, Shijie Li, Zhiyuan Yao, Jiahao Hu, Jiasheng Cao, Win Topatana, Sarun Juengpanic, Hong Yu, Jiliang Shen, Ming-Yu Chen
Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis. Journal of gastroenterology and hepatology 36 (2) (2020)

Win Topatana.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Win Topatana